All In MedTech

Device Trial Radar · NCT05610787

EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

40

Planned (sponsor's estimate)

Start

Nov 14, 2022

Primary completion

Nov 10, 2023

Study completion Jan 2027

Sponsor

Lead sponsor
Berlin Heart, IncNot on our public-company list
Sponsor type
Industry
First posted
Nov 9, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Driving System while being used with the approved EXCOR Pediatric Ventricular Assist Device. EXCOR Active Driving System is intended for use with the approved EXCOR Pediatric VAD. The EXCOR Pediatric VAD is intended to provide mechanical circulatory support as a bridge to cardiac transplantation for pediatric patients. Pediatric candidates with severe isolated left ventricular or biventricular dysfunction who are candidates for cardiac transplant and require circulatory support may be treated using the EXCOR Pediatric. EXCOR Active is intended for use in a clinical setting. EXCOR Active can be used in any kind of hospital unit (e.g. OR, ICU, intermediate care unit or general care unit). The driving unit may be moved between clinical units using the caddy or baby buggy; however, a patient must always be accompanied by a person trained in the use of the manual pump and emergency procedures during transport in the event of an emergency. The driving unit can be transported during operation.

Conditions

  • Heart Failure
  • Transplant; Failure, Heart
  • Congenital Heart Disease

Interventions

  • EXCOR Active Driving System for Pediatric VADDevice

    The EXCOR Active Driving System - will be used with the EXCOR Pediatric VAD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Device Malfunction adverse eventsTime frame: Up to 90 days
  2. Patient OutcomeTime frame: Up to 90 days
  3. Serious Adverse EventsTime frame: Up to 90 days

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital of Los Angeles

    Los Angeles, California

  • Lucile Packard Children's Hospital-Stanford

    Palo Alto, California

  • Children's Hospital Colorado

    Aurora, Colorado

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.